Altimmune, Inc. (ALT) vs Valneva SE Sponsored ADR (VALN)
Altimmune, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Altimmune, Inc. and Valneva SE Sponsored ADR are of similar size ($593.3M and $589.8M). Altimmune, Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 65.3×. Altimmune, Inc. grew revenue faster over the last twelve months: 130.0% against −53.2%. Altimmune, Inc. has the higher net margin (0.00% vs −12.0%) and the lower return on invested capital (−34.3% vs 0.00%). Across the 17 metrics below, Valneva SE Sponsored ADR leads on 10 and Altimmune, Inc. on 7.
Valuation
Profitability
| Metric | ALT | VALN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 38.28% | 65.16% |
| Operating margin | 0.00% | 13.56% | 0.00% |
| Net margin | 0.00% | (12.01%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (28.87%) | 0.00% | (57.72%) |
| Return on assets | (25.58%) | 0.00% | (49.22%) |
| Return on invested capital | (34.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack